EUVIMEDEUVIMED entdecken
Crossref

Randomized phase 3 trial of fluorouracil, epirubicin, and cyclophosphamide alone or followed by paclitaxel for early breast cancer

Chau Dang

Current Breast Cancer Reports · 2009

DOI: 10.1007/s12609-009-0001-9 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Current Breast Cancer Reports, 2009. Verfasst von Chau Dang. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 10 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Dang, C. (2009). Randomized phase 3 trial of fluorouracil, epirubicin, and cyclophosphamide alone or followed by paclitaxel for early breast cancer. Current Breast Cancer Reports. https://doi.org/10.1007/s12609-009-0001-9

Vancouver

Dang C. Randomized phase 3 trial of fluorouracil, epirubicin, and cyclophosphamide alone or followed by paclitaxel for early breast cancer. Current Breast Cancer Reports. 2009. doi:10.1007/s12609-009-0001-9

BibTeX
@article{Dang2009,
  author = {Dang, Chau},
  title = {Randomized phase 3 trial of fluorouracil, epirubicin, and cyclophosphamide alone or followed by paclitaxel for early breast cancer},
  journal = {Current Breast Cancer Reports},
  year = {2009},
  doi = {10.1007/s12609-009-0001-9}
}
Kostenlos starten →